A.17 Imipenem + cilastatin + relebactam - bacterial infections due to multidrug-resistant organisms

A.17 Imipenem + cilastatin + relebactam – bacterial infections due to multidrug-resistant organisms

Application, expert reviews and public comments

Application

A.17 Imipenem + cilastatin + relebactam – bacterial infections due to multidrug-resistant organisms

Comments

Médecins Sans Frontières

WHO Technical Advisory Group on AWaRe

TAG-AWaRe advice for the 2025 Expert Committee

Expert reviews

Expert Review 1

Expert Review 2

WHO department comments

AMR Surveillance, Prevention and Control